Log in
NYSE:ALB

Albemarle Stock Forecast, Price & News

$89.28
+2.42 (+2.79 %)
(As of 09/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$87.22
Now: $89.28
$90.13
50-Day Range
$80.42
MA: $92.55
$100.45
52-Week Range
$48.89
Now: $89.28
$101.00
Volume1.35 million shs
Average Volume1.58 million shs
Market Capitalization$9.50 billion
P/E Ratio21.67
Dividend Yield1.77%
Beta1.41
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets. It also offers cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for various pyrotechnical applications; technical services, such as the handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The company's Bromine Specialties segment offers bromine and bromine-based solutions for fire safety, chemical synthesis, mercury control, water purification, beef and poultry processing, and other industrial applications, as well as oil and gas well drilling, and completion fluids applications; and tertiary amines, biocides, disinfectants, and sanitizers. Its Catalysts segment offers performance catalyst solutions comprising hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. The company was founded in 1994 and is headquartered in Charlotte, North Carolina.
Read More
Albemarle logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 2.7Dividend Strength: 4.2Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.23 out of 5 stars


Industry, Sector and Symbol

Industry Plastics materials & resins
Sub-IndustrySpecialty Chemicals
CUSIP01265310
Phone980-299-5700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.59 billion
Cash Flow$8.53 per share
Book Value$38.61 per share

Profitability

Net Income$533.23 million

Miscellaneous

Employees6,000
Market Cap$9.50 billion
Next Earnings Date11/4/2020 (Confirmed)
OptionableOptionable
$89.28
+2.42 (+2.79 %)
(As of 09/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ALB News and Ratings via Email

Sign-up to receive the latest news and ratings for ALB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Albemarle (NYSE:ALB) Frequently Asked Questions

How has Albemarle's stock price been impacted by COVID-19?

Albemarle's stock was trading at $70.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ALB stock has increased by 27.4% and is now trading at $89.28.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Albemarle?

26 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 6 sell ratings, 12 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Albemarle
.

When is Albemarle's next earnings date?

Albemarle is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Albemarle
.

How can I listen to Albemarle's earnings call?

Albemarle will be holding an earnings conference call on Wednesday, November 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Albemarle's earnings last quarter?

Albemarle Co. (NYSE:ALB) announced its quarterly earnings results on Wednesday, August, 5th. The specialty chemicals company reported $0.86 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.72 by $0.14. The specialty chemicals company had revenue of $764.05 million for the quarter, compared to analysts' expectations of $704.31 million. Albemarle had a return on equity of 13.33% and a net margin of 12.99%.
View Albemarle's earnings history
.

How often does Albemarle pay dividends? What is the dividend yield for Albemarle?

Albemarle announced a quarterly dividend on Tuesday, July 14th. Shareholders of record on Friday, September 18th will be paid a dividend of $0.385 per share on Thursday, October 1st. This represents a $1.54 dividend on an annualized basis and a yield of 1.72%. The ex-dividend date is Thursday, September 17th.
View Albemarle's dividend history
.

What guidance has Albemarle issued on next quarter's earnings?

Albemarle updated its third quarter 2020 After-Hours earnings guidance on Wednesday, August, 5th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $700-775 million, compared to the consensus revenue estimate of $717.55 million.

What price target have analysts set for ALB?

26 analysts have issued twelve-month target prices for Albemarle's stock. Their forecasts range from $40.00 to $116.00. On average, they anticipate Albemarle's share price to reach $79.83 in the next year. This suggests that the stock has a possible downside of 10.6%.
View analysts' price targets for Albemarle
.

Are investors shorting Albemarle?

Albemarle saw a drop in short interest in August. As of August 14th, there was short interest totaling 10,530,000 shares, a drop of 13.6% from the July 30th total of 12,190,000 shares. Based on an average daily volume of 1,180,000 shares, the days-to-cover ratio is currently 8.9 days. Currently, 10.0% of the shares of the stock are sold short.
View Albemarle's Short Interest
.

Who are some of Albemarle's key competitors?

What other stocks do shareholders of Albemarle own?

Who are Albemarle's key executives?

Albemarle's management team includes the following people:
  • Mr. Luther C. Kissam IV, Chairman, Pres & CEO (Age 54)
  • Mr. Scott A. Tozier, Exec. VP & CFO (Age 53)
  • Mr. Donald J. LaBauve Jr., VP, Corp. Controller & Chief Accounting Officer (Age 52)
  • Ms. Karen G. Narwold, Exec. VP, Chief Admin. Officer, Gen. Counsel & Corp. Sec. (Age 59)
  • Mr. David Ryan, VP of Corp. Strategy & Investor Relations

What is Albemarle's stock symbol?

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

How do I buy shares of Albemarle?

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Albemarle's stock price today?

One share of ALB stock can currently be purchased for approximately $89.28.

How big of a company is Albemarle?

Albemarle has a market capitalization of $9.50 billion and generates $3.59 billion in revenue each year. The specialty chemicals company earns $533.23 million in net income (profit) each year or $6.04 on an earnings per share basis. Albemarle employs 6,000 workers across the globe.

What is Albemarle's official website?

The official website for Albemarle is www.albemarle.com.

How can I contact Albemarle?

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]

This page was last updated on 10/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.